Board Room
National Academy of Sciences Building
2101 Constitution Avenue, NW
Washington, DC 20418

March 25, 2003
9:00a.m. to 4:45p.m.

The Workshop is Free and Open to the Public

9:30      WELCOME AND INTRODUCTION    Ed Penhoet, Committee Chair

9:35      NCI Programs to Support Development of New Approaches to Breast Cancer
            Detection
            Ed Staab, Branch chief, Diagnostic Imaging, NCI

10:15    Research and Development Strategies in Molecular Imaging Technologies
            (Unable to Attend)    
            H. Donald Burns, Group Head, PET Research, Merck

10:55    Regulatory Challenges for In Vitro Diagnostics   
            Joseph Hackett, Special Projects Officer, Office of In Vitro Diagnostics, FDA

11:35    Challenges in Assessing the Safety and Efficacy of Cancer Detection Devices
            David Feigal, Director, Center for Devices and Radiological Heath, FDA

12:15    DISCUSSION

12:30    LUNCH

1:15      CMS Perspective on Adoption of New Breast Cancer Detection Technologies
             Sean Tunis, Acting Chief Medical Officer, CMS

1:55      Private Health Payers’ Perspective on Adoption of New Breast Cancer
            Detection Technologies
            Alan Rosenberg, Vice President of Medical and Credentialing Policy, WellPoint Health
            Networks

2:35      DISCUSSION

2:50      BREAK

3:10      Better Information and Decision Tools: The Needs of the Consumer
            Mary Ropka, University of Virginia Medical School

3:50      Decision Support in Breast Cancer Detection Options: Health Systems
            Perspective
            Nananda Col, Brigham & Women’s Hospital

4:30      DISCUSSION

4:45      ADJOURN